SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-115441
Filing Date
2020-10-16
Accepted
2020-10-16 06:04:46
Documents
1
Period of Report
2020-10-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 tm2033244d1_form3.html 3  
1 FORM 3 tm2033244d1_form3.xml 3 1476
  Complete submission text file 0001104659-20-115441.txt   3033
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Issuer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SYNERGY PHARMACEUTICALS INC. 420 LEXINGTON AVE NEW YORK NY 10020
Business Address
Sender Gary (Reporting) CIK: 0001659085 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35023 | Film No.: 201242714